Micro-RNA profiling in kidney and bladder cancers
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
TNM Classification of Malignant Tumours
(1987) · Springer eBooks · doi:10.1007/978-3-642-82982-6 · Cited by 16,049
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
MicroRNA expression profiles classify human cancers
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,539
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
Self-citationJemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Smigal, C., & Thun, M. J. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.2.106 · Cited by 5,314
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307323101 · Cited by 4,095
Self-citationMicroRNA Gene Expression Deregulation in Human Breast Cancer
Iorio, M. V., Ferracin, M., Liu, C.-G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1783 · Cited by 4,053
Self-citationTNM Classification of Malignant Tumours
(2003) · John Wiley & Sons, Inc. eBooks · doi:10.1002/0471463752 · Cited by 3,946
RAS Is Regulated by the let-7 MicroRNA Family
Johnson, S. M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., Labourier, E., Reinert, K. L., Brown, D., & Slack, F. J. (2005) · Cell · doi:10.1016/j.cell.2005.01.014 · Cited by 3,656
Cited by
Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., Guo, J., Zhang, Y., Chen, J., Guo, X., et al. (2008) · Cell Research · doi:10.1038/cr.2008.282 · Cited by 4,560
MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death
Schickel, R., Boyerinas, B., Park, S.-M., & Peter, M. E. (2008) · Oncogene · doi:10.1038/onc.2008.274 · Cited by 719
Yang, M., Chen, J., Su, F., Yu, B., Su, F., Lin, L., Liu, Y., Huang, J.-D., & Song, E. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-117 · Cited by 693
“miR-223 has been implicated in the progression of renal [26] and hepatocellular cancers [27].”
BackgroundZhou, L., Chen, J., Li, Z., Li, X., Hu, X., Huang, Y., Zhao, X., Liang, C., Wang, Y., Sun, L., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015224 · Cited by 641
MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma
Fornari, F., Gramantieri, L., Ferracin, M., Veronese, A., Sabbioni, S., Calin, G. A., Grazi, G. L., Giovannini, C., Croce, C. M., Bolondi, L., et al. (2008) · Oncogene · doi:10.1038/onc.2008.178 · Cited by 639
Self-citationHanke, M., Hoefig, K., Merz, H., Feller, A. C., Kausch, I., Jocham, D., Warnecke, J. M., & Sczakiel, G. (2010) · Urologic Oncology: Seminars and Original Investigations · doi:10.1016/j.urolonc.2009.01.027 · Cited by 638
MicroRNAs and complex diseases: from experimental results to computational models
Chen, X., Xie, D., Zhao, Q., & You, Z.-H. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbx130 · Cited by 638
Coordinate Regulation of FOXO1 by miR-27a, miR-96, and miR-182 in Breast Cancer Cells
Guttilla, I. K., & White, B. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.031427 · Cited by 560
MicroRNAs as regulators of epithelial-mesenchymal transition
Gregory, P. A., Bracken, C. P., Bert, A. G., & Goodall, G. J. (2008) · Cell Cycle · doi:10.4161/cc.7.20.6851 · Cited by 506
MicroRNA in Prostate, Bladder, and Kidney Cancer: A Systematic Review
Catto, J. W. F., Alcaraz, A., Bjartell, A. S., De Vere White, R., Evans, C. P., Fussel, S., Hamdy, F. C., Kallioniemi, O., Mengual, L., Schlomm, T., et al. (2011) · European Urology · doi:10.1016/j.eururo.2011.01.044 · Cited by 469
Greither, T., Grochola, L. F., Udelnow, A., Lautenschläger, C., Würl, P., & Taubert, H. (2010) · International Journal of Cancer · doi:10.1002/ijc.24687 · Cited by 448
Markou, A., Tsaroucha, E. G., Kaklamanis, L., Fotinou, M., Georgoulias, V., & Lianidou, E. S. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.101741 · Cited by 441
“Upregulation of miR-205 was observed in bladder cancer ( 23 ) as well as in adult mouse corneal and footpad epithelium (24).”
BackgroundLebanony, D., Benjamin, H., Gilad, S., Ezagouri, M., Dov, A., Ashkenazi, K., Gefen, N., Izraeli, S., Rechavi, G., Pass, H., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.4134 · Cited by 408
Stanczyk, J., Ospelt, C., Karouzakis, E., Filer, A., Raza, K., Kolling, C., Gay, R., Buckley, C. D., Tak, P. P., Gay, S., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30115 · Cited by 407
Identification of novel microRNA targets based on microRNA signatures in bladder cancer
Ichimi, T., Enokida, H., Okuno, Y., Kunimoto, R., Chiyomaru, T., Kawamoto, K., Kawahara, K., Toki, K., Kawakami, K., Nishiyama, K., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24390 · Cited by 404
Hanson, E. K., Lubenow, H., & Ballantyne, J. (2009) · Analytical Biochemistry · doi:10.1016/j.ab.2009.01.037 · Cited by 378
Coordinated epigenetic repression of the miR‐200 family and miR‐205 in invasive bladder cancer
Wiklund, E. D., Bramsen, J. B., Hulf, T., Dyrskjøt, L., Ramanathan, R., Hansen, T. B., Villadsen, S. B., Gao, S., Ostenfeld, M. S., Borre, M., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25461 · Cited by 367
Dyrskjøt, L., Ostenfeld, M. S., Bramsen, J. B., Silahtaroglu, A. N., Lamy, P., Ramanathan, R., Fristrup, N., Jensen, J. L., Andersen, C. L., Zieger, K., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4043 · Cited by 363
Gandellini, P., Folini, M., Longoni, N., Pennati, M., Binda, M., Colecchia, M., Salvioni, R., Supino, R., Moretti, R., Limonta, P., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2894 · Cited by 358
Suppression of cell growth and invasion by miR-205 in breast cancer
Wu, H., Zhu, S., & Mo, Y.-Y. (2009) · Cell Research · doi:10.1038/cr.2009.18 · Cited by 358
Malzkorn, B., Wolter, M., Liesenberg, F., Grzendowski, M., Stühler, K., Meyer, H. E., & Reifenberger, G. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00328.x · Cited by 352
“Nevertheless, in line with our findings, miR-28 showed increased expression in renal cell carcinomas as compared to normal kidney tissue (19).”
ResultMultiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3′ untranslated region
Wu, S., Huang, S., Ding, J., Zhao, Y., Liang, L., Liu, T., Zhan, R., & He, X. (2010) · Oncogene · doi:10.1038/onc.2010.34 · Cited by 346
miR221/222 in Cancer: Their Role in Tumor Progression and Response to Therapy
Garofalo, M., Quintavalle, C., Romano, G., M. Croce, C., & Condorelli, G. (2012) · Current Molecular Medicine · doi:10.2174/156652412798376170 · Cited by 331
Distinct MicroRNA Alterations Characterize High- and Low-Grade Bladder Cancer
Catto, J. W. F., Miah, S., Owen, H. C., Bryant, H., Myers, K., Dudziec, E., Larré, S., Milo, M., Rehman, I., Rosario, D. J., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0744 · Cited by 329
Chhabra, R., Dubey, R., & Saini, N. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-232 · Cited by 324
VHL and HIF signalling in renal cell carcinogenesis
Baldewijns, M. M., van Vlodrop, I. J., Vermeulen, P. B., Soetekouw, P. M., van Engeland, M., & de Bruïne, A. P. (2010) · The Journal of Pathology · doi:10.1002/path.2689 · Cited by 316
Dysregulation of microRNAs in cancer: Playing with fire
Melo, S. A., & Esteller, M. (2011) · FEBS Letters · doi:10.1016/j.febslet.2010.08.009 · Cited by 315
MicroRNA-221 Targets Bmf in Hepatocellular Carcinoma and Correlates with Tumor Multifocality
Gramantieri, L., Fornari, F., Ferracin, M., Veronese, A., Sabbioni, S., Calin, G. A., Grazi, G. L., Croce, C. M., Bolondi, L., & Negrini, M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0092 · Cited by 308
Self-citationThe miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition
Cloonan, N., Brown, M. K., Steptoe, A. L., Wani, S., Chan, W. L., Forrest, A. R., Kolle, G., Gabrielli, B., & Grimmond, S. M. (2008) · Genome Biology · doi:10.1186/gb-2008-9-8-r127 · Cited by 304
“By contrast, over-expression of the mir-17-92 locus has been identified in lung cancers [3], chronic myeloid leukemias [6], B-cell and mantle cell lymphomas [2,8], hepatocellular tumors [9], bladder cancers [10], and breast, colon, pancreas, prostate, and stomach solid tumors [11].”
MicroRNA involvement in hepatocellular carcinoma
Gramantieri, L., Fornari, F., Callegari, E., Sabbioni, S., Lanza, G., Croce, C. M., Bolondi, L., & Negrini, M. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00533.x · Cited by 304
Self-citationPodocyte-Specific Loss of Functional MicroRNAs Leads to Rapid Glomerular and Tubular Injury
Ho, J., Ng, K. H., Rosen, S., Dostal, A., Gregory, R. I., & Kreidberg, J. A. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008020162 · Cited by 297
MicroRNA‐205–directed transcriptional activation of tumor suppressor genes in prostate cancer
Majid, S., Dar, A. A., Saini, S., Yamamura, S., Hirata, H., Tanaka, Y., Deng, G., & Dahiya, R. (2010) · Cancer · doi:10.1002/cncr.25488 · Cited by 294
PhenomiR: a knowledgebase for microRNA expression in diseases and biological processes
Ruepp, A., Kowarsch, A., Schmidl, D., Buggenthin, F., Brauner, B., Dunger, I., Fobo, G., Frishman, G., Montrone, C., & Theis, F. J. (2010) · Genome Biology · doi:10.1186/gb-2010-11-1-r6 · Cited by 284
MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism
Yang, M., Yao, Y., Eades, G., Zhang, Y., & Zhou, Q. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1604-1 · Cited by 280
MicroRNA-184 antagonizes microRNA-205 to maintain SHIP2 levels in epithelia
Yu, J., Ryan, D. G., Getsios, S., Oliveira-Fernandes, M., Fatima, A., & Lavker, R. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803992105 · Cited by 276
MicroRNA profiling of human gastric cancer
Huang (2009) · Molecular Medicine Reports · doi:10.3892/mmr_00000199 · Cited by 271
Nakada, C., Matsuura, K., Tsukamoto, Y., Tanigawa, M., Yoshimoto, T., Narimatsu, T., Nguyen, L., Hijiya, N., Uchida, T., Sato, F., et al. (2008) · The Journal of Pathology · doi:10.1002/path.2437 · Cited by 269
MicroRNA Expression Signatures of Bladder Cancer Revealed by Deep Sequencing
Han, Y., Chen, J., Zhao, X., Liang, C., Wang, Y., Sun, L., Jiang, Z., Zhang, Z., Yang, R., Chen, J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018286 · Cited by 266
Micromarkers: miRNAs in cancer diagnosis and prognosis
Ferracin, M., Veronese, A., & Negrini, M. (2010) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.10.11 · Cited by 266
Self-citationComprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients
Dai, Y., Sui, W., Lan, H., Yan, Q., Huang, H., & Huang, Y. (2009) · Rheumatology International · doi:10.1007/s00296-008-0758-6 · Cited by 265
HGIMDA: Heterogeneous graph inference for miRNA-disease association prediction
Chen, X., Yan, C. C., Zhang, X., You, Z.-H., Huang, Y.-A., & Yan, G.-Y. (2016) · Oncotarget · doi:10.18632/oncotarget.11251 · Cited by 232
“Experiments indicated that the histopathology of Kidney Neoplasm has been connected with different genetic changes [90, 91].”
BackgroundIdentification of a MicroRNA Panel for Clear-cell Kidney Cancer
Juan, D., Alexe, G., Antes, T., Liu, H., Madabhushi, A., Delisi, C., Ganesan, S., Bhanot, G., & Liou, L. S. (2010) · Urology · doi:10.1016/j.urology.2009.10.033 · Cited by 225
Role of microRNAs in kidney homeostasis and disease
Chandrasekaran, K., Karolina, D. S., Sepramaniam, S., Armugam, A., Marelyn Wintour, E., Bertram, J. F., & Jeyaseelan, K. (2012) · Kidney International · doi:10.1038/ki.2011.448 · Cited by 219
MiR-107 and MiR-185 Can Induce Cell Cycle Arrest in Human Non Small Cell Lung Cancer Cell Lines
Takahashi, Y., Forrest, A. R. R., Maeno, E., Hashimoto, T., Daub, C. O., & Yasuda, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006677 · Cited by 219
MicroRNA‐125b suppresses the development of bladder cancer by targeting E2F3
Huang, L., Luo, J., Cai, Q., Pan, Q., Zeng, H., Guo, Z., Dong, W., Huang, J., & Lin, T. (2011) · International Journal of Cancer · doi:10.1002/ijc.25509 · Cited by 208
“Recently, it has been reported that microRNAs may act as oncogenes or tumor suppressors in various cancers.(7) MicroRNAs belong to a class of small (19-22nt) non-protein-coding RNAs that regulate gene expression through complementary binding to the 30 untranslated region (UTR) of target mRNAs.”
BackgroundStrand-Specific miR-28-5p and miR-28-3p Have Distinct Effects in Colorectal Cancer Cells
Almeida, M. I., Nicoloso, M. S., Zeng, L., Ivan, C., Spizzo, R., Gafà, R., Xiao, L., Zhang, X., Vannini, I., Fanini, F., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.047 · Cited by 202
Self-citationZhang, Z., Zhang, B., Li, W., Fu, L., Fu, L., Zhu, Z., & Dong, J.-T. (2011) · Genes & Cancer · doi:10.1177/1947601911429743 · Cited by 182
Koh, C. M., Iwata, T., Zheng, Q., Bethel, C., Yegnasubramanian, S., & De Marzo, A. M. (2011) · Oncotarget · doi:10.18632/oncotarget.327 · Cited by 180
Zhou, Y., Wan, G., Spizzo, R., Ivan, C., Mathur, R., Hu, X., Ye, X., Lu, J., Fan, F., Xia, L., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2013.09.004 · Cited by 169
Self-citationFornari, F., Pollutri, D., Patrizi, C., La Bella, T., Marinelli, S., Casadei Gardini, A., Marisi, G., Baron Toaldo, M., Baglioni, M., Salvatore, V., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1464 · Cited by 168
“1–3), as well as in other cancers, such as glioblastoma (4, 5), papillary thyroid carcinoma (6, 7), pancreatic cancer (8), prostate (9), melanoma (10), breast (11), kidney, and bladder cancers (12).”
BackgroundSelf-citationOttman, R., Nguyen, C., Lorch, R., & Chakrabarti, R. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-1 · Cited by 162
“Among the other up regulated miRNAs, over expression of let-7f1 [42], miR-143 [46], miR-218 [50], miR29a [55], miR-302a [57], miR-3144 [59], miR-493 [62] and miR-664 [63] in cancer cells has been reported earlier.”
BackgroundmiR-23b* targets proline oxidase, a novel tumor suppressor protein in renal cancer
Liu, W., Zabirnyk, O., Wang, H., Shiao, Y.-H., Nickerson, M. L., Khalil, S., Anderson, L. M., Perantoni, A. O., & Phang, J. M. (2010) · Oncogene · doi:10.1038/onc.2010.237 · Cited by 160
“Some of these have not been reported in previous studies (Gottardo et al., 2007; Nakada et al., 2008), which may be because of biological and technical differences, including different analytical platforms or number of miRNA probes used.”
MiR‐205 silences MED1 in hypoxic primary human trophoblasts
Mouillet, J., Chu, T., Nelson, D. M., Mishima, T., & Sadovsky, Y. (2010) · The FASEB Journal · doi:10.1096/fj.09-149724 · Cited by 125
“tumors (78, 79), but down-regulation in breast and”
BackgroundLoss of microRNA-205 expression is associated with melanoma progression
Liu, S., Tetzlaff, M. T., Liu, A., Liegl-Atzwanger, B., Guo, J., & Xu, X. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.62 · Cited by 74
SHIP2 and its involvement in various diseases
Suwa, A., Kurama, T., & Shimokawa, T. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.492780 · Cited by 74
Li, B., Sun, M., Gao, F., Liu, W., Yang, Y., Liu, H., Cheng, Y., Liu, C., & Cai, J. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000356607 · Cited by 54
Self-citationRole of microRNAs in HTLV-1 infection and transformation
Ruggero, K., Corradin, A., Zanovello, P., Amadori, A., Bronte, V., Ciminale, V., & D’Agostino, D. M. (2010) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2010.05.001 · Cited by 41
Metadata
- Authors
- Gottardo, F., Liu, C. G., Ferracin, M., Calin, G. A., Fassan, M., Bassi, P., Sevignani, C., Byrne, D., Negrini, M., Pagano, F., Gomella, L. G., Croce, C. M., & Baffa, R.
- Venue
- Urologic Oncology: Seminars and Original Investigations
- Publisher
- Elsevier BV
- Published
- 2007-09
- Volume
- 25
- Issue
- 5
- Pages
- 387-392
- ISSN
- 1078-1439 (ISSN-L)
- OpenAlex
- W2039164708
- Cited by
- 600
- References
- 28
- FWCI
- 15.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.